TY  -  
T1  - Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents : analysis of CVD-REAL data 
SN  -  /  
UR  - http://hdl.handle.net/10138/334647 
T3  -  
A1  - CVD-REAL Investigators Study Grp; Khunti, Kamlesh; Kosiborod, Mikhail; Kim, Dae Jung; Eriksson, Johan G.; Fenici, Peter 
A2  -  
PB  -  
Y1  - 2021 
LA  - eng 
AB  - Background Randomized, controlled cardiovascular outcome trials may not be fully representative of the management of patients with type 2 diabetes across different geographic regions. We conducted analyses of data from the multinational CVD-REAL consortium to determine the association between initiation of sodium-glucose cotransporter-2 inhibitors (SGLT-2i) and cardiovascular outcomes, including subgroup analyses based on patient characteristics. Methods De-identified health records from 13 coun... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - Sodium-glucose cotransporter-2 inhibitors; Cardiovascular outcomes; Heart failure; Type 2 diabetes; RISK; INITIATION; THERAPIES; MORTALITY; TRIALS; DEATH; ASIA; 3121 General medicine, internal medicine and other clinical medicine 
N1  -   
PP  -  
ER  -